Verastem Inc
NASDAQ:VSTM
Verastem Inc
Common Shares Outstanding
Verastem Inc
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Verastem Inc
NASDAQ:VSTM
|
Common Shares Outstanding
$25.3m
|
CAGR 3-Years
21%
|
CAGR 5-Years
32%
|
CAGR 10-Years
28%
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Verastem Inc's Common Shares Outstanding?
Common Shares Outstanding
25.3m
USD
Based on the financial report for Dec 31, 2023, Verastem Inc's Common Shares Outstanding amounts to 25.3m USD.
What is Verastem Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
28%
Over the last year, the Common Shares Outstanding growth was 51%. The average annual Common Shares Outstanding growth rates for Verastem Inc have been 21% over the past three years , 32% over the past five years , and 28% over the past ten years .